PCR 2013
 
Members: Sign In
 
 
About|Testimonials|Background|Recent Surveys
 
Report: PCR 2013
 
 
  Date Jan 2013
  Pages 201
  Participants 733
  Region Global
  Countries 84
Contents
1. Conduct of Study
2. Study Participants
3. PCR Techniques
4. PCR Applications
5. PCR Company Suppliers
6. Preferred Suppliers/Products
7. Expenditure and Budgets
8. Purpose
9. Samples
10. Sample Preparation
11. Therapeutic Area
12. Disease Biomarkers
13. Bioinformatics Software
14. Challenging Applications
15. Innovation 
16. Quality Control
17. PCR Consumables
18. Discussion
19. Appendices (1 – 6) 
This report
This report provides support
in the following areas:
● Funding applications 
● Purchase decisions
● Professional development
● Development planning
● Collaboration 
● Innovation
● Budget planning
● Problem-solving
● Benchmarking
 
A report containing the full data from this survey, is provided free of charge to survey participants.
Overview of Report
This report presents the findings of a global end-user survey carried out in the PCR field, which involved the participation of 733 PCR users in 84 countries. An overview of this survey is presented below.

Routine use: Use of PCR by end-users for running routine (developed and validated) PCR tests, the development or validation of PCR tests and for the qualitative discovery using PCR methods 
Suppliers: Purchases of PCR and related systems by end-users from more than 25 companies and anticipated PCR purchases by end-users from more than 25 companies over the next three years, each ranked according to their competitive position. 
PCR Methods: Current use of more than 30 PCR techniques by end-users and the anticipated use of these techniques by end-users over the next three years, each ranked according to their competitive position.
PCR Application: Current use of 12 leading PCR applications by end-users and the anticipated use of these applications by end-users over the next three years, each ranked according to their competitive position. 
Preferred Suppliers: End-users’ preferred companies in the PCR field, each ranked according to their competitive position.
Products: End-users’ preferred products (and associated companies) in the PCR field, each ranked according to their competitive position.
Strengths: End-users’ disclosures of the strengths of their preferred products in the PCR field, each ranked according to their competitive position.
Weaknesses: End-users’ disclosures of the weaknesses of their preferred products in the PCR field, each ranked according to their relative position.
Current Financial Budgets: End-users’ annual financial budgets for PCR studies.
Current Budget Breakdown: The breakdown of end-users’ PCR financial budgets in eight key areas, relating to their current expenditure on PCR products and activities. 
Future Budget Breakdown: The breakdown of end-users’ PCR financial budgets in eight key areas, relating to their anticipated expenditure over the next three years, on PCR products and activities.
Future Financial Budgets: End-users’ anticipated changes (percentage increases or decrease) over the next three years, relating to their PCR activities
Consumables: End-users’ top three consumables, associated with their PCR activities.
Quality Control Guidelines: End-users’ adherence to established quality control guidelines or procedures, relating to the conduct of PCR studies.
Current Challenges: End-users’ disclosures on molecular types that present the greatest technical challenges to PCR analysis, together with the associated sample types (matrices), associated PCR methods and underlying reasons. 
Innovation: End-users’ current needs relating to 12 key areas of required innovation in the PCR field, each ranked (on a scale of 1 to 10) according to their importance. 
Recent Innovations: End-users disclosures on the most important innovations relating to their use of PCR, over the last three years. 
Future Innovation: End-users’ disclosures on what they anticipate will be the most important innovations in the PCR field, over the next three years. 
Biomarkers: End-users’ application of PCR methods for the study of disease biomarkers, including molecular types and their clinical utilities.
Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres. 
Fields: End-users underlying fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities. 
Bioinformatics Software: End-users’ disclosures on their preferred bioinformatics software, associated with PCR studies.
Purpose: End-users’ underlying reasons for using PCR analysis across 13 major fields (biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance. 
Study Samples: Study sample types analysed by end-users using PCR methods, each ranked according to their relative importance. 
Sample Preparation: The use of sample preparation methods by end-users for PCR studies, each ranked according to their importance.

 

Of course, your motive would be to buy a perfect gift at the replica watches sale cost possible but never compromise on the quality of the product for price. The easiest way to ensure the quality of the breitling replica uk is to stick to popular brands. There are renowned brands like Skagen, Casio, Fastrack, Titian, Timex and so on that sell replica watches sale at the lowest cost possible. All these popular brands offer a wide variety of rolex replica sale, each model designed to suit a specific class of customers. Each of rolex replica sale brands is popular in offering a specific range of timepieces. For instance, the Casio G-Shock series offer high-graded rubber strap replica watches that are designed to withstand tough conditions.